Wenbo Han

Title: Innovations in Cancer Therapy by Inventor Wenbo Han

Introduction

Wenbo Han is a notable inventor based in Chicago, IL, who has made significant contributions to the field of cancer therapy. With a total of three patents to his name, his work focuses on innovative methods to enhance the efficacy of cancer treatments.

Latest Patents

One of Wenbo Han's latest patents involves the combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy. This patent describes nanoparticles comprising micheliolide (MCL) or its derivatives, which can be combined with additional therapeutic agents, such as chemotherapeutic agents. The methods outlined in this patent aim to treat diseases like cancer by utilizing combinations of MCL or its derivatives with X-ray irradiation and other therapeutic agents, including immune checkpoint inhibitors. The synergistic effects of these combinations can enhance anticancer therapeutic efficacy, as MCL or its derivatives can sensitize cancer cells to therapy while targeting resistant cancer stem cells (CSCs) for selective cell death.

Career Highlights

Wenbo Han is affiliated with the University of Chicago, where he continues to advance research in cancer therapy. His innovative approaches have the potential to transform treatment methodologies and improve patient outcomes.

Collaborations

Wenbo Han collaborates with esteemed colleagues, including Wenbin Lin and Christina Chan, to further his research and development efforts in the field of cancer therapy.

Conclusion

Wenbo Han's contributions to cancer therapy through his innovative patents highlight the importance of research in developing effective treatment strategies. His work exemplifies the potential of combining novel therapeutic agents to enhance cancer treatment efficacy.